A final point related to this concept is the necessity for precise knowledge about IDO1 and IL4i1 expression; as high-quality anti-human IDO1 and IL4i1 antibodies are available, tissue staining for the cell types and approximate amounts of either enzyme in a cancer biopsy is imperative to guide inhibitor use. Here, IL4I1 is linked to cancer.